Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study.
Quintana-Castanedo L, Sánchez-Ramón S, Maseda R, Illera N, Pérez-Conde I, Molero-Luis M, Butta N, Arias-Salgado EG, Monzón-Manzano E, Zuluaga P, Martínez-Santamaría L, Fernández-Arquero M, Llames SG, Meana Á, de Lucas R, Del Río M, Vicente Á, Escámez MJ, Sacedón R. Quintana-Castanedo L, et al. Among authors: de lucas r. Exp Dermatol. 2024 Aug;33(8):e15146. doi: 10.1111/exd.15146. Exp Dermatol. 2024. PMID: 39075828 Free PMC article.
Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial.
Fiorillo L, Becker E, de Lucas R, Belloni-Fortina A, Armesto S, Elewski B, Maes P, Oberoi RK, Paris M, Zhang W, Zhang Z, Arkin L. Fiorillo L, et al. Among authors: de lucas r. J Am Acad Dermatol. 2024 Jun;90(6):1232-1239. doi: 10.1016/j.jaad.2023.11.068. Epub 2024 Jan 23. J Am Acad Dermatol. 2024. PMID: 38266683 Free article. Clinical Trial.
A new topical biotechnological phytocomplex for truncal mild-moderate acne restores skin microbiota balance.
Guerra-Tapia A, Martínez H, Nieto C, Ruiz Alonso C, Bermejo R, Carrón N, Garcia-Segura S, Gonzalez-Torres P, Palacios-Martínez D, Bou L, Pérez M, De Lucas R. Guerra-Tapia A, et al. Among authors: de lucas r. Skin Res Technol. 2024 Jul;30(7):e13806. doi: 10.1111/srt.13806. Skin Res Technol. 2024. PMID: 39044362 Free PMC article. Clinical Trial.
New clinical approach in facial mild-moderate acne: Re-stabilization of skin microbiota balance with a topical biotechnological phytocomplex.
De Lucas R, Martínez H, Nieto C, Ruiz-Alonso C, Bermejo R, Carrón N, Garcia-Segura S, Gonzalez-Torres P, Palacios-Martínez D, Guerra-Tapia A, Bou L, Pérez M. De Lucas R, et al. J Cosmet Dermatol. 2024 Nov;23(11):3616-3627. doi: 10.1111/jocd.16452. Epub 2024 Aug 28. J Cosmet Dermatol. 2024. PMID: 39205505 Clinical Trial.
Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients.
de Lucas R, Moreno-Arias G, Perez-López M, Vera-Casaño Á, Aladren S, Milani M; ACTUO Investigators study group. de Lucas R, et al. BMC Dermatol. 2015 Sep 11;15:17. doi: 10.1186/s12895-015-0036-8. BMC Dermatol. 2015. PMID: 26361978 Free PMC article.
Consensus Statement from the Spanish Academy of Dermatology and Venereology (AEDV) Psoriasis Working Group (SWG) and Pediatric Working Group (PWG) on the Management of Pediatric Psoriasis.
Vicente A, Pérez-Ferriols A, Batalla A, García-Fernandez L, Pérez B, Eiris N, de Lucas R, De La Cueva P, Carrascosa JM. Vicente A, et al. Among authors: de lucas r. Actas Dermosifiliogr. 2024 Jul 18:S0001-7310(24)00597-0. doi: 10.1016/j.ad.2024.06.007. Online ahead of print. Actas Dermosifiliogr. 2024. PMID: 39032783 English, Spanish.
153 results